Influenza Surveillance In the WHO African Region

Similar documents
PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

IMMUNIZATION VACCINES & EMERGENCIES

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

IMMUNIZATION & VACCINE PREVENTABLE DISEASES

AIDS in Africa. An Update. Basil Reekie

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

TFI Proceedings, Recommendations and implications for 2005

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

Global reductions in measles mortality and the risk of measles resurgence

Influenza Weekly Surveillance Bulletin

Annex 2 A. Regional profile: West Africa

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

Aboubacar Kampo Chief of Health UNICEF Nigeria

Scaling Up Nutrition Action for Africa

Performance of National Measles Case-Based Surveillance Systems in The WHO African Region

Influenza Update N 159

CANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD

1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

Ageing and mental health resources for older persons in the African region of the World Health Organization

What is this document and who is it for?

CDER EDITORIAL Through this issue of the

Fertility and Family Planning in Africa: Call for Greater Equity Consciousness

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

Influenza Update N 176

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

Influenza Update N 157

UNAIDS 2013 AIDS by the numbers

Regional Consultation on Nutrition and HIV/AIDS in French Speaking Countries in Africa Region

Excellence and Originality from Necessity: Palliative Care in Africa. Dr Emmanuel Luyirika Executive Director, African Palliative Care Association

POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY

Main global and regional trends

MEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

ASLM Building laboratory capacity in Africa in a sustainable way

Ouagadougou Declaration

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012

Specific issues related to FMD surveillance in the eastern Africa sub-region. Gideon Brückner

Bi-weekly Influenza Situation Update

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Influenza Weekly Surveillance Bulletin

511,000 (57% new cases) ~50,000 ~30,000

Rift Valley Fever. What is Rift Valley Fever?

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Prioritizing Emergency Polio Eradication Activities

Impact of Pathology Implementation Strategies in Sub Saharan Africa

IMMUNIZATION VACCINE DEVELOPMENT

Addressing climate change driven health challenges in Africa

PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva

IMMUNIZATION VACCINE DEVELOPMENT

Bi-weekly Influenza Situation Update

Expert Group Meeting on the Regional Report for the African Gender and Development Index

Wild Poliovirus Weekly Update

Bi-weekly Influenza Situation Update

Objectives of Rotavirus Surveillance

Yellow fever Vaccine investment strategy

! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!

Bi-weekly Influenza Situation Update

ASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare

Influenza Weekly Surveillance Bulletin

THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL: 10 YEARS OF IMPLEMENTATION IN THE AFRICAN REGION

PROGRESS REPORT ON DECADE OF TRADITIONAL MEDICINE IN THE AFRICAN REGION. Progress Report. CONTENTS Paragraphs BACKGROUND PROGRESS MADE...

Progress has been made with respect to health conditions.

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods

Outbreaks and Emergencies Bulletin

Food Production and Violent Conflict in Sub-Saharan Africa. - Supplementary Information -

Comparative Analyses of Adolescent Nutrition Indicators

Bi-weekly Influenza Situation Update

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa

Influenza Update N 162

CDC s Commitment to National Laboratory Systems to Achieve Global Health Security

Update on Meningococcal A Vaccine Development and Introduction

Demographic Transitions, Solidarity Networks and Inequality Among African Children: The Case of Child Survival? Vongai Kandiwa

REGIONAL OVERVIEW AND PERSPECTIVES ON SOCIAL DETERMINANTS OF HEALTH IN AFRICA


EBOLA SITUATION REPORT

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

AFRICA. The continent of All challenges

Regulatory Capacity Building and Developing Countries: CBER Perspective

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 4, 26 May 2012

Yellow fever laboratory capacity on-site assessments in Africa: preliminary findings

Health situation analysis in the African Region. Basic indicators 2006

Update from GAVI Aurelia Nguyen

FP2020 Expert Advisory Community Webinar

Health systems and HIV: advocacy. Interagency Coalition on AIDS and Development

REPORT ON THE SPECIAL SESSION ON IDENTIFYING THE PUBLIC HEALTH RESEARCH NEEDS FOR INFLUENZA IN AFRICA 4 JUNE 2010, MARRAKESH, MOROCCO

TURNING POINT FOR AFRICA AN HISTORIC OPPORTUNITY TO END AIDS AS A PUBLIC HEALTH THREAT BY 2030 AND LAUNCH A NEW ERA OF SUSTAINABILITY

Global summary of the AIDS epidemic, December 2007

Vol. 5 Issue 2, 31 May 2015

ENHANCING THE ROLE OF TRADITIONAL MEDICINE IN HEALTH SYSTEMS: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat EXECUTIVE SUMMARY

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network

World Organisation for Animal Health Protecting animals, Preserving our future 1

African Gender and Development Index

Influenza Weekly Surveillance Bulletin


Transcription:

Vol. 2 N 52, Updated on 2 January 207 Contents Highlights ackground Methodology Review of 206 influenza virus circulation Seasonal patterns of influenza transmission Way forward Conclusion Editor Dr Ibramima Socé-Fall Director, WHE Programme Influenza Surveillance In the WHO African to 52, 206 HIGHLIGTHS Nineteen of the 23 (83%) Member States of the influenza laboratory network shared influenza virological data from epidemiological weeks to 52 of 206. A total of 34,553 specimens were tested, 6% of which were positive for influenza virus. The predominant circulating virus was influenza type A, accounting for 62% of the positive specimens, of which 56% were influenza subtype. Senegal (western African zone), South Africa (southern African zone) and Algeria (northern African zone) exhibited seasonal patterns of influenza transmission, while the majority of countries in the other African zones had no seasonality. Priority in the WHO Africa region for 207 is to further enhance influenza surveillance through integration of virological and epidemiological surveillance data. Editorial oard Dr. Impouma, Dr Y. Zabulon, Dr M.D. Harouna, Dr A.A. Yahaya, Dr. A. Talisuna Contributors Dr. S.C. Rajatotonirina, Dr. E. Hamblion, Dr. C. Okot, Dr. A. Oke, Dr R. Wango Mr. C. Massidi, Mr. A. Moussongo ACKGROUND The occurrence of the avian influenza outbreak in 2006 and influenza HN pandemic in 2009 triggered coordinated regional activities to better prepare for future outbreaks. These activities included human capacity building for influenza sentinel surveillance and diagnosis, creation of the influenza laboratory network, infrastructure and technology transfer to selected laboratories. So far, 34 countries out of 47 in the WHO African region have developed influenza laboratory diagnostic capacity using the minimum standards recommended by WHO 2. The African influenza virological surveillance network was established in 2006 to characterize the different epidemiological profiles within this expansive continent, which has vastly different climatic conditions. This lead to a better understanding of the epidemiology of influenza in the region and therefore development of more timely and appropriate response mechanisms. However, there is still a paucity of data on the epidemiology of influenza in the WHO African region. The African al (AFR) influenza laboratory network is responsible for biological monitoring of circulating viral type/subtype. This enables WHO, in collaboration with partners and the pharmaceutical industry, to better define the choice of viruses for inclusion in future influenza vaccines. To date, the 23 countries 3 of the AFR influenza laboratory network are implementing sentinel surveillance for Influenza-Like Illness (ILI) and/or Severe Acute Respiratory Infection (SARI) and contributing to weekly influenza surveillance reporting. This is in addition to surveillance data received through FluNet, the global web-based tool for influenza virological surveillance. The purpose of the weekly influenza surveillance bulletin is to monitor the influenza activity in the region by zone of transmission and to provide information on the seasonal pattern. This last report for 206 provides a review of influenza activity from epidemiological (epi) weeks to 52 in the region. ) Algeria, Angola, urkina Faso, urundi, Cameroon, Central African Republic, Chad, Congo, Cote d Ivoire, DR Congo, Ethiopia, Gabon, Guinea, Ghana, Kenya, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Niger, Nigeria, Rwanda, Senegal, Seychelles, Sierra Leone, South Africa, Tanzania, Togo, Uganda, Zambia and Zimbabwe. 2) http://www.afro.who.int/en/integrated-disease-surveillance/publications/395-lab-capacity-requirements-for-ihr-and-their-implementation-in-the-who-afro.html 3) Algeria, urkina Faso, Cameroon, Central African Republic, Cote d Ivoire, DR Congo, Ethiopia, Ghana, Kenya, Madagascar, Mali, Mauritania, Mauritius, Mozambique, Niger, Nigeria, Rwanda, Senegal, South Africa, Tanzania, Togo, Uganda, and Zambia.

METHODOLOGY Data collected for this bulletin meets the standardized case definitions for ILI and SARI as defined by WHO 4. National Influenza Centres (NICs) and National Influenza Reference laboratories (NIRL) were provided with a standardized electronic form to collect aggregated data on the number of specimens received and processed, the number that tested positive for influenza and the number of each type/subtype of influenza virus identified. Data presented in this bulletin was collected according to the epi week calendar and shared 5 every Friday of the following epi week. The influenza virus A subtypes reported include A(HN) pandemic (),, A(H5N) and A(unsubtyped). Influenza activity is based on the positivity rate for influenza samples tested. Completed data is defined as data reported for every epi week of 206. Member countries of the AFR influenza laboratory network are classified into five zones of transmission to facilitate the analysis of seasonal patterns of influenza. REVIEW OF 206 INFLUENZA VIRUS CIRCULATION Nineteen of the 23 (83%) member countries of the AFR influenza laboratory network shared influenza virological data from epi weeks to 52 of 206. Four countries (Kenya, Nigeria, the Democratic Republic of Congo and Tanzania) did not submit data for all the weeks of the year. A total of 34,553 specimens were tested and 6% were positive for influenza virus. The predominant influenza virus circulating was influenza type A, constituting 62% of positive specimens, 56% of which were influenza influenza subtype, 32% A(HN) subtype and 2% A(unsubtyped). No human avian influenza virus A(H5N) subtype was detected throughout the year. During 205 influenza A(HN) subtype was the predominant virus circulating in the region, particularly during the first half of the year. Conversely, in 206 influenza A(HN) was the predominant subtype circulating in the region up to epi week 6; subsequently increased influenza activity were reported from epi weeks 7 to 40 ; while Influenza activity increased during the last quarter of 206 from epi weeks 40 to 52. In 206 influenza activity started late compared to 205, a notable increase in influenza activity was observed from epi week 28 which persisted for the remainder of 206 while increased influenza activity was observed during the first 6 months in 205. (Figure ) Figure : Trend of influenza viruses reported in the WHO African, epi weeks to 52, 206 Figure a : Countries reporting influenza surveillance data, epi weeks to 52, 206 0 200 400 600 800 000 Influenza data The distribution of virus type/subtype by zone of transmission is shown in Figure 2. The most frequently reported influenza type/subtype in 206 was influenza in western African zone (positivity rate of 7%), influenza type in middle African zone (positive rate of 2%), eastern African zone (positive rate of 8%) and in southern African zone (positive rate of 3%), and influenza A(HN) in northern African zone (positive rate of 3%). Figure 2 : Geographic distribution of influenza viruses circulating in the WHO African by zone of transmission, epi weeks to 52, 206 W N S EE SEASONAL PATTERNS OF INFLUENZA TRANSMISSION The WHO African is similar to both the WHO Western Pacific and WHO Americas/PAHO regions in that it spans both the northern and southern hemispheres. Furthermore, seasonal patterns of influenza transmission exist in Senegal (western African zone) in addition to South Africa (southern African zone) and Algeria (northern African zone) with the majority of countries in the other African zones exhibiting no seasonality. 4) http://www.afro.who.int/en/integrated-disease-surveillance/publications/4792-protocol-for-national-influenza-sentinel-surveillance.html 5) Data from Madagascar is not included in this bulletin as not shared to AFRO reporting channel. 2

In the northern African zone, comprising only of Algeria, a total of 509 specimens were tested and 47% were positive for influenza irus (Figure 3). The predominant influenza virus circulating was influenza type A (79% of positive specimens), which included 57% of influenza A(HN) subtype and 44% of influenza subtype (Figure 4). The seasonality of influenza activity concurs with patterns observed in the countries of the northern hemisphere, from epi weeks 3 to 2 of 206. The peak of transmission was observed from epi weeks 7 to 9 of 206, which coincided with the northern hemisphere winter and influenza type A was predominant. This is similar to what was observed during the same period in 205. There was a second increase in influenza activity from epi weeks 48 to 5 of 206 predominated by influenza type contrary to what was observed during the same period in 205. Figure 3 : Trend of influenza viruses in the northern African zone of transmission, epi weeks to 52, 206 Northern Africa 206 Figure 3a : Country from northern African zone of transmission reporting data, epi weeks to 52, 206 Number of Number samples of 0 00 200 300 400 Influenza data Figure 4: Trend of influenza viruses in Algeria, epi weeks to 52, 205-206 0 20 40 60 80 00 20 205 205 206 0 20 40 60 80 00 20 06 2 A(HN) 03 8 5 A(HN) 0 8 48 2 In the southern African zone (Figure 5), which includes South Africa, a total of 7,458 specimens were type A (54 rate) 53% was influenza subtype and 47% was influenza A(HN) subtype. In the southern African zone, influenza transmission peaked in epi weeks 33 to 35, corresponding to the southern hemisphere winter. Influenza type activity predominated during the first part of the seasonal influenza epidemic (epi weeks 8 to 28) followed by influenza type A (epi weeks 29 to 38) (Figure 6). During the seasonal influenza epidemic of 205, influenza type A was predominant (epi weeks 9 to 28). Figure 5 : Trend of influenza viruses in the southern African zone of transmission, epi weeks to 52, 206 Southern Africa 206 Figure 5a : Country from southern African zone of transmission reporting data, epi weeks to 52, 206 Number of Number samples of 0 00 200 300 400 Influenza data 3

Figure 6 : Trend of influenza viruses in South Africa, epi weeks to 52, 205-206 South Africa 205 South Africa 206 Number 0 50 00 50 200 250 300 205 206 Number 0 50 00 50 200 250 300 205 206 A(HN) 29 27 427 In Senegal there was little influenza activity throughout 206 compared to 205. A total of,826 specimens were tested and 6% were positive for influenza virus (33% of influenza tested positive in 205). The predominant influenza virus circulating was influenza type A (98% of positive specimens) which included 87% of influenza subtype and 3% of influenza A(HN) subtype. There was a brief increase in influenza activity from epi weeks 34 to 43, with a peak of transmission during epi week 38 (Figure 7). In Senegal, influenza surveillance from 996 to 2009 has shown that influenza activity consistently peaks during the rainy season from July to October, the same was seen in 206. This contrasted with data from 205 where in addition to the usual influenza circulation during the rainy season, an unusual influenza activity was observed in January with a predominance of influenza A(HN) subtype. This was probably related to the international context particularly the influenza spread in the northern hemisphere. Figure 7 : Trend of influenza viruses in Senegal, epi weeks to 52, 205-206 Senegal 206 0 20 40 60 80 00 05 Number of 206 0 20 40 60 80 00 205 206 A(HN) 27 247 For the other African zones, there is no clear pattern of seasonality with continuous transmission of influenza throughout 206 with the exception of Togo, and the Central African Republic where influenza activity was neither seasonal nor continuous but showed uncharacteristic peaks in activity. (Figures 8,9,0) Figure 8 : Trend of influenza viruses in the western African zone of transmission, epi weeks to 52, 206 Figure 8a : Countries from western African zone of transmission reporting data, epi weeks to 52, 206 0 00 200 300 400 Influenza data 4

Figure 9 : Trend of influenza viruses in the middle African zone of transmission, epi weeks to 52, 206 Middle Africa 206 Figure 9a : Countries from Middle African zone of transmission reporting data, epi weeks to 52, 206 Number of 0 00 200 300 400 Influenza data Figure 0 : Trend of influenza viruses in the eastern African zone of transmission, epi weeks to 52, 206 Figure 0a : Countries from eastern African zone of transmission reporting data, epi weeks to 52, 206 Eastern Africa 206 Number of 0 00 200 300 400 Influenza data In Togo, a total of 730 specimens were tested and 3% were positive for influenza virus. The predominant influenza virus circulating was influenza type (68% positive specimens). Influenza activity registered two peaks of distribution, each of which was exclusively composed of one of two influenza types. Influenza subtype predominated from epi weeks 9 to 25, while influenza type circulated from epi weeks 39 to 5. (Figure ) Figure : Trend of influenza viruses in Togo, epi weeks to 52, 205-206 0 0 20 30 40 50 205 205 206 0 0 20 30 40 50 206 2 A(HN) 6 52 2 A(HN) 0 52 2 IN THE WHO 53

In the Central African Republic a total of,687 specimens were tested and % were positive for influenza virus. The predominant influenza virus circulating was influenza type A (79% positive specimens) which included 78% of influenza subtype and 22% of influenza A(HN) subtype. It is worth noting that no influenza activity was observed in the Central African Republic until epi week 8 with influenza subtype predominant from epi weeks 27 to 33. (Figure 2) Figure 2: Trend of influenza viruses in Central African Republic, epi weeks to 52, 205-206 0 20 40 60 80 05 205 206 06 0 20 40 60 80 A(HN) 23 08 WAY FORWARD Strengthening of the influenza surveillance system should be undertaken in a step-wise manner. Countries should first ensure that they have the capacity to diagnose influenza viruses and determine seasonal epidemics. Next, the virological surveillance should be enhanced by the integration of epidemiological and virological surveillance data in order to ensure appropriate decision making through the knowledge of the burden of influenza disease. Lastly, collaboration between the human and animal interface should be put in place for better preparation, an early warning system, early detection and rapid response in case of spread. The top priorities in our region for 207 to further enhance influenza surveillance are the integration of virological and epidemiological surveillance data which is crucial for improved decision making and the expansion of the network to other countries for better preparedness. The availability of the AFR influenza sentinel surveillance training modules will help countries to reach these critical objectives, by i) addressing the epidemiological, virological and data management components of surveillance in one training program, ii) training personnel from all areas involved in surveillance activities, and iii) providing a standardized training program instituting best practices for sentinel surveillance for Member States. CONCLUSION Influenza virological surveillance data collected during the past five years demonstrates that influenza virus activity seems to vary depending on climate and geographic location. This seasonality is clearly observed in Algeria, Senegal and South Africa. The data collected from countries, as part of influenza sentinel surveillance, will better inform predictions of the timing of influenza activity and preparedness for increases in acute respiratory infections, and importantly the introduction of influenza vaccines. Furthermore, the data describes the extent of virus circulation in the region and possible repercussions on health systems and socio-economic development, since influenza epidemics contribute to a high rate of absenteeism. Sentinel surveillance also contributes to the established early warning systems so that a potential outbreak from a new virus subtype(s) can be rapidly identified and contained. ACKNOWLEDGMENT We would like to thank all the countries and the teams of individuals who are actively involved in influenza surveillance in Africa for their diligence and commitment to influenza surveillance in the region. To end, we would also like to thank all the partners who support the WHO African region in strengthening the influenza surveillance system. 6